Induction of Tolerance Allows Separation of Lethal and Antitumor Activities of Tumor Necrosis Factor in Mice

Cancer Research

Volumn 51, Issue 9, 1991, Pages 2366-2372

  Takahashi, Nozomi ^a   Brouckaert, Peter ^a   Fiers, Walter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; LETHALITY; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0025779994     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72:3666-3670, 1975.
2. Haranaka, K., Satomi, N., and Sakurai, A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int. J. Cancer, 34: 263-267, 1984.
3. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Ill, Zentella, A., Albert, J. D., Shires, G. T., and Cerami, A. Shock and tissue injury induced by recombinant human cachectin. Science (Washington DC), 234:470-474,1986.
4. Havell, E. A., Fiers, W., and North, R. J. The antitumor function of tumor necrosis factor (TNF). 1. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J. Exp. Med., 167: 1067-1085,1988.
5. Brouckaert, P. G. G., Leroux-Roels, G. G., Guisez, Y., Tavern ier, J., and Fiers, W. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-γ, on a syngeneic murine melanoma. Int. J. Cancer, 38:763-769, 1986.
6. Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei, E., Ill, and Kufe, D. W. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J. Natl. Cancer Inst., 80:1039-1044,1988.
7. Kettelhut, I. C., Fiers, W., and Goldberg, A. L. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc. Natl. Acad. Sci. USA, 84:4273-4277, 1987.
8. Marquet, R. L., IJzermans, J. N. M., De Bruin, R. W. F., Fiers, W., and Jeekel, J. Anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) on colon cancer in rats is promoted by recombinant rat interferon gamma; toxicity is reduced by indomethacin. Int. J. Cancer, 40: 550-553, 1987.
9. Fransen, L., Van der Heyden, J., Ruysschaert, R., and Fiers, W. Recombinant tumor necrosis factor its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines. Eur. J. Cancer Clin. Oncol., 22:419-426, 1986.
10. Talmadge, J. E., Black, P. L., Tribble, H., Pennington, R., Bowersox, O., Schneider, M., and Phillips, H. Preclinical approaches to the treatment of metastatic disease: Therapeutic properties of rH TNF, rM IFN-γ, and rH IL-2. Drugs Exp. Clin. Res., 13:327-337,1987.
11. Brouckaert, P., Everaerdt, B., and Fiers, W. In vivo effects of human rTNF and murine rTNF in mice. Immunobiology, 175:47-48,1987.
12. Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., Cerami, A., and Lowry, S. F. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med., 167:1211-1227,1988.
13. Stovroff, M. C., Fraker, D. L., Swedenborg, J. A., and Norton, J. A. Cachectin/tumor necrosis factor a possible mediator of cancer anorexia in the rat. Cancer Res., 48:4567-4S72,1988.
14. Socher, S. H., Friedman, A., and Martinez, D. Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J. Exp. Med., 167:1957-1962,1988.
15. Patton, J. S., Peters, P. M., McCabe, J., Crase, D., Hansen, S., Chen, A. B., and Liggitt, D. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-a in rodents. J. Clin. Invest., 80:1587-1596,1987.
16. Fraker, D. L., Stovroff, M. C., Merino, M. J., and Norton, J. A. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J. Exp. Med., 168:95-105,1988.
17. Grunfeld, C., Wilking, H., Neese, R., Gavin, L. A., Moser, A. H., Gulli, R., Serio, M. K., and Feingold, K. R. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res., 49:2554-2560,1989.
18. Mahony, S. M., and Tisdale, M. J. Role of prostaglandins in tumour necrosis factor induced weight loss. Br. J. Cancer, 60:51-55, 1989.
19. Hart, l. R. The selection and characterization of an invasive variant of the BI6 melanoma. Am. J. Pathol., 97:587-600, 1979.
20. Fransen, L., Muller, R., Marmenout, A., Tavemier, J., Van der Heyden, J., Kawashima, E., Chollet, A., Tizard, R., Van Heuverswyn, H., Van Vliet, A., Ruysschaert, M. R., and Fiers, W. Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res., 13: 4417-4429,1985.
21. Ostrove, J., and Gifford, G. Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor. Proc. Soc. Exp. Biol. Med., 160: 354-358, 1979.
22. Balkwill, F. R., Lee, A., Aldam, G., Moodie, E., Thomas, J. A., Tavemier, J., and Fiers, W. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res., 46:3990-3993, 1986.
23. Mendenhawl, W. Introduction to Probability and Statistics. North Scituate, MA: Duxbury Press, 1979.
24. Asher, A., Mule, J. J., Reichert, C. M., Shiloni, E., and Rosenberg, S. A. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J. Immunol., 138:963-974,1987.
25. Talmadge, J. E., Tribble, H. R., Pennington, R. W., Phillips, H., and Wiltrout, R. H. Immunomodulatory and immunotherapeutic properties of recombinant γ-interferon and recombinant tumor necrosis factor in mice. Cancer Res., 47:2563-2570, 1987.
26. Hohmann, H. P., Remy, R., Brockhaus, M., and Van Loon, A. P. G. M. Two different cell types have different nuyor receptors for human tumor necrosis factor (TNFa). J. Biol. Chem., 264:14927-14934, 1989.
27. Wallach, D., Holtmann, H., Engelmann, H., and Nophar, Y. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-I. J. Immunol., 140:2994-2999,1988.
28. Waage, A., and Espevik, T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor a/cachectin in mice. J. Exp. Med., 167: 1987-1992, 1988.
29. Libert, C., Van Bladel, S., Brouckaert, P., Shaw, A., and Fiers, W. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J. Immunol., in press, 1991.
30. Fraker, D. L., Sheppard, B. C., and Norton, J. A. Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice. Cancer Res., 50:22612267, 1990.
31. Lehmann, V., Freudenberg, M. A., and Galanos, C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med., 165:657-663,1987.
32. Rothstein, J. L., and Schreiber, H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. USA, 85:607-611,1988.
33. Brouckaert, P. G., Everaerdt, B., Libert, C., Takahashi, N., and Fiers, W. Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in mice. Agents Actions, 26: 196-198,1989.
34. Brouckaert, P. G., Libert, C., Everaerdt, B., Takahashi, N., and Fiers, W. A role for interleukin 1 in the in vivo actions of tumor necrosis factor. Lym-phokine Res., 8:269-274,1989.